There was an obvious trend toward increasing use of MIS in sleeve lobectomy patients during the study period (7.7% in 2013 to 36% in 2018), as shown in Figure 2 .
← all excerpts
Minimally invasive sleeve lobectomy for centrally located lung cancer: A real-world study with propensity-score matching.
1
—
—